Concepedia

Jeffrey J. Ackroyd

JJ

15

Publications

1.5K

Citations

12

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Harvard University

Beth Israel Deaconess Medical Center

University of Michigan

Jeffrey J. Ackroyd is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

2013–2023

15

Publications

15

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 903 citations · Full text

, , +4

Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

Pingping Hou, Avnish Kapoor, Qiang Zhang et al. · Cancer Discovery · 2020 · 145 citations · Full text

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 95 citations · Full text

, , +5

A Purine Nucleotide Biosynthesis Enzyme Guanosine Monophosphate Reductase Is a Suppressor of Melanoma Invasion

Joseph A. Wawrzyniak, Anna Bianchi, Wiam Bshara et al. · Cell Reports · 2013 · 58 citations · Full text

Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity

Anna Bianchi, Joseph A. Wawrzyniak, Archis Bagati et al. · Cell Death and Differentiation · 2015 · 49 citations · Full text

, , +8

Rows per page

1–5 of 15